Sudden death due to leukostasis in a subject with undiagnosed chronic lymphocytic leukemia.
Lorenzo GittoRohin MehtaKanish MirchiaChristopher RamosMichel TawilSerenella SerinelliPublished in: Forensic science, medicine, and pathology (2021)
Sudden death due to leukostasis and lymphocyte thrombi in patients with chronic hematologic malignancies is rare. Leukostasis is characterized by highly elevated leukemic cell count and decreased tissue perfusion symptoms, leading to severe complications and even death. Chronic lymphocytic leukemia (CLL) is a chronic lymphoproliferative disorder that shows a highly heterogeneous clinical course, ranging from indolent form to very aggressive disease. Due to its low metabolic and mitotic rate, there is a lower incidence of clinically significant leukostasis in patients with CLL. Two main theories have been proposed in the development of leukostasis: (1) increased blood viscosity due to large leukemic cell populations; (2) high metabolic activity and cytokine production by leukemic cells. Both mechanisms lead to local hypoxic damage.We present a case of a 70-year-old man who died suddenly in the absence of symptoms. Autopsy and histology examinations revealed findings consistent with CLL and diffuse leukostasis involving the major organs' vessels.In the presence of gross and/or microscopic findings suggesting a potential hematologic malignancy, undiagnosed or relapsing hematologic malignancies should be considered in the differential diagnosis of sudden deaths.
Keyphrases
- chronic lymphocytic leukemia
- single cell
- acute myeloid leukemia
- multiple sclerosis
- risk factors
- cell therapy
- induced apoptosis
- magnetic resonance imaging
- sleep quality
- early onset
- stem cells
- low grade
- signaling pathway
- rheumatoid arthritis
- physical activity
- risk assessment
- computed tomography
- cell proliferation
- hodgkin lymphoma
- diffuse large b cell lymphoma
- bone marrow
- depressive symptoms
- high grade